Human Fetal Tissue Transplantation

Over the past decade there have been major advances in the field of regenerative medicine with the promise to bring to reality, cures for debilitating diseases such as diabetes, heart failure, and Parkinson’s disease. Cellular products from a variety of sources are being evaluated for their ability...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Bhattacharya, Niranjan (Επιμελητής έκδοσης), Stubblefield, Phillip (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: London : Springer London : Imprint: Springer, 2013.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03248nam a22004455i 4500
001 978-1-4471-4171-6
003 DE-He213
005 20150519185518.0
007 cr nn 008mamaa
008 130220s2013 xxk| s |||| 0|eng d
020 |a 9781447141716  |9 978-1-4471-4171-6 
024 7 |a 10.1007/978-1-4471-4171-6  |2 doi 
040 |d GrThAP 
050 4 |a RB45 
072 7 |a MJF  |2 bicssc 
072 7 |a MED038000  |2 bisacsh 
082 0 4 |a 616.15  |2 23 
245 1 0 |a Human Fetal Tissue Transplantation  |h [electronic resource] /  |c edited by Niranjan Bhattacharya, Phillip Stubblefield. 
264 1 |a London :  |b Springer London :  |b Imprint: Springer,  |c 2013. 
300 |a XXIX, 462 p. 124 illus., 92 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Part I The ideas behind this book -- Part II Basic Science and the unique aspect of fetal growth and maturation -- Part III Fetal Cell transplant experiments in animal and human systems -- Part IV Fetal tissue transplant experiments in animal and human systems -- Part V Fetal Organ transplant experiments in animal and human systems -- Part VI Biobanking -- Ethics of fetal tissue transplant. 
520 |a Over the past decade there have been major advances in the field of regenerative medicine with the promise to bring to reality, cures for debilitating diseases such as diabetes, heart failure, and Parkinson’s disease. Cellular products from a variety of sources are being evaluated for their ability to replace damaged tissue. Fetal tissues consist of stem cells and progenitor cells which have undergone initial commitment with varying states of differentiation. Stem cells from fetal tissues may also have a greater proliferative potential than their adult counterparts. In addition, fetal derived stem and progenitor cells are immunologically naive and some sources of fetal cells, eg cord blood, have been shown to be capable of crossing greater HLA mismatching resulting in less rejection and decreased immune mediated toxicities. Given the increasing focus on HES and advances in our basic knowledge of regenerative medicine it is an appropriate time to review the biology and use of fetal tissues. Human Fetal Tissue Transplantation is a timely publication that provides details of many aspects of the potential use of fetal tissues for therapeutic applications. As many tissues are wasted on a daily basis it appropriate to raise discussion on how to maximize access to discard tissue and at the same time engage in discussion of the ethics associated with fetal tissue procurement and clinical use. 
650 0 |a Medicine. 
650 0 |a Hematology. 
650 0 |a Pathology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Hematology. 
650 2 4 |a Pathology. 
700 1 |a Bhattacharya, Niranjan.  |e editor. 
700 1 |a Stubblefield, Phillip.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781447141709 
856 4 0 |u http://dx.doi.org/10.1007/978-1-4471-4171-6  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)